Protocol of Diuretics Use in Congestive Therapy in Heart Failure
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 299 participants.
Also called NCT03892148
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 299 participants
- Registry
-
NCT03892148
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT03892148. Randomized; triple masking; primary purpose treatment. Start 2019-05-17 (actual); primary completion 2023-01-16 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Protocol of Diuretics Use in Congestive Therapy in Heart Failure
- Acronym
- ProDUCT-HF
- Condition
- Heart Failure
- Condition
- Acute Heart Failure
- Condition
- Chronic Heart Failure
- Intervention (Drug)
- Furosemide
- Intervention (Drug)
- Hydrochlorothiazide
- Lead sponsor
- University Hospital, Clermont-Ferrand
- Collaborator
- University Hospital, Grenoble
- Collaborator
- Hospices Civils de Lyon
- Collaborator
- Hôpital de la Croix-Rousse
- Collaborator
- CH Puy en Velay
- Collaborator
- CH Moulins-Yzeure
- Collaborator
- CH Riom
- Collaborator
- Infirmerie Protestante de Lyon
- Collaborator
- CH Issoire
- Collaborator
- CH Annecy Genevois
Record details
- Record id
cardio:ct-nct03892148- Content hash
6151d6ad554224928d824da6678667102d39376e05294f3755bce92b702e042f